How Covaxin became a victim of vaccine triumphalism
29 min read 26 May 2021, 04:08 PM IST Join usPriyanka Pulla
Many believe that the hastened approval of Covaxin hurt the reputation of the Make-in-India campaign, instead of bolstering it
On the 30th of March 2021, the Brazilian drug regulator published a worrying report on its website, pointing to flaws in how Hyderabad-based Bharat Biotech was making Covaxin, its Covid-19 vaccine.
Select your Category